#44 – Jeremy Schaap, ESPN journalist: upsets, doping, triumphs, and the importance of sports

Attia explains this in response to Schaap's question about why Lance Armstrong was not caught earlier while using EPO, pivoting to explain why testosterone — despite being more physiologically potent — is actually more detectable than EPO and HGH. The practical implication for longevity-oriented readers: men on TRT who are also competitive athletes should understand that their protocol will produce a detectable signature, and that off-label cycling of testosterone can be identified by the LH/FSH suppression pattern even when T levels appear normal at the time of testing.

Attia explicitly says: 'I think human growth hormone I don't have a lot of experience with it even clinically. I know how effective it is but I think it's used pretty rampantly. My intuition is that that is certainly in most sports got to be the drug of choice right now.' The clinical corollary for longevity patients: HGH is one of the few PEDs whose long-term harm profile is genuinely uncertain, which compounds the testing problem — we don't know the detection ceiling AND we don't know the ceiling for harm.

The broader clinical context Attia supplies: in the 1990s/early 2000s, ICU cascade management was far less sophisticated than today. Some of the Schaap complications might be survivable with modern critical care. But the lesson is structural: elective procedures impose a non-trivial mortality risk on otherwise-healthy patients, and that risk is not zero even with modern medicine. Attia's comment — 'you didn't have any tools to help somebody having a heart attack back then the way we do today' — applies equally to managing surgical complications. The principle is to treat elective procedures as optional interventions with mandatory risk-benefit quantification, not as routine calendar events.

Schaap makes explicit the contrast between Braddock (who 'had the scent of desperation so recently in his nostrils' and was literally fighting to feed his three children) and Max Baer (who 'thought this was show business and it was a way for him to make a buck'). The motivational asymmetry was visible to everyone but translated directly into competitive outcome. The Douglas case is even cleaner because the acute grief event can be dated precisely — and Douglas himself described his mother's death as what made the fight unavoidable.

The broader framing from Schaap: every element of Braddock's apparent misfortune — the broken hand, the poverty, the stevedore labor, the 20-mile daily commute — 'may have prepared him in a way he hadn't been prepared to seize the moment.' This maps directly to the anti-fragility principle from Taleb: the structure (Braddock's physique and technique) was made stronger by stressors that appeared to be destructive. Exercise physiologists recognize cross-education of strength as a formal phenomenon — training the contralateral limb prevents atrophy and may enhance recovery. Braddock was unknowingly running a years-long cross-education protocol.

Schaap's self-critique is precise: 'I wish I approached that story with more skepticism. The Andros story seemed to put everything at rest... the subject was kind of taboo... everybody was celebrating this... I was around Mark [McGwire] every day for like a month plus... now everything I saw was fake.' The mechanism of failure: cultural taboo + collective excitement + access without leverage = uncritical coverage. The same mechanism operates in wellness media when a celebrity endorses a protocol. Being in the room does not equal having sufficient distance to ask the adversarial question.

Attia explains that exogenous testosterone suppresses the pituitary hormones that normally stimulate its production — luteinizing hormone and follicle-stimulating hormone — so those suppressed levels become a detection signal. HGH lacks this feedback signature. Schaap makes the further observation that track and field will 'always be full of growth hormone' precisely because of undetectability, and that declarations of clean sport in that context are largely performative.

Tyson himself, when Schaap interviewed him in 2017, acknowledged that Douglas was the better fighter that specific day — while claiming that if he'd approached the fight with 'full commitment' he would have won. Schaap rejects the revisionism: the point is that on that day, under those conditions, Douglas performed at a level nobody had ever seen from him before or after. The mother's death was not just tragic context; it appears to have been a direct performance amplifier.

Schaap notes this is why the Braddock story sounds like a fairy tale — every element of his poverty and desperation, from the relief office to the dockwork, 'may have prepared him in a way he hadn't been prepared to seize the moment.' The broken right hand was not just an injury — it was the stimulus that drove cross-training of the weaker limb, a phenomenon exercise physiologists now recognize as a formal adaptation principle.

The conversation occurs in the context of discussing whether the cycling doping era was 'worse' than baseball steroids. Attia's framing: the detection gap between testosterone and HGH is a fundamental pharmacological property, not an institutional failure — which is why declaring the current era 'clean' requires specifying which substances are actually testable.

Attia himself makes the comment that in the era of Dick Schaap's death, the acute interventional tools for managing a deteriorating hospital patient were far less developed than today — 'you didn't have any tools to help somebody having a heart attack back then the way we do today.' This contextualizes the Schaap case: not purely a preventable error story but also a story about the era-specific limits of critical care. Jeremy's account of being told his father was recovering, only to have him die two days later, illustrates the false-positive recovery signals that mislead families during cascade failures.